EXPERIENCE WITH THE TYROSINE KINASE INHIBITOR CABOZANTINIB IN THE REPUBLIC OF BASHKORTOSTAN

K.V. Menshikov1,2, A.V. Sultanbaev1, Sh.I. Musin1, A.A. Izmaylov1,2, I.A. Menshikova2, A.F. Nasretdinov1, N.I. Sultanbaeva1, D.O. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Menshikov Konstantin V. ― Cand. of Sci. (Med.), Associate Professor of the Department of Oncology with courses on oncology and pathological anatomy of IAPE of the Bashkir State Medical … Читать далее

DYSFUNCTIONS OF THE THYROID GLAND ON THE BACKGROUND OF MEDICINAL THERAPY OF MALIGNANT NOVELTIES (LITERATURE REVIEW)

A.D. Gafiullina1, Z.A. Afanasyeva2 1Tatarstan Саnсеr Center, Kazan 2Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan Afanasyeva Z.A. ― D. Med. Sc., professor of the Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, secretary … Читать далее

EFFECTIVE USE OF TARGETED DRUGS IN THE TREATMENT OF METASTATIC COLORECTAL CANCER

E.S. Lyubimtseva Nizhny Novgorod Regional Clinical Oncology Center, Nizhny Novgorod Lyubimtseva E.S ― Head of the 5th Department for Chemotherapy of Nizhny Novgorod Regional Clinical Oncology Center 1 Ankundinovskoe highway, Nizhny Novgorod, 603081, tel. (831) 465-15-58, e-mail: ludimtseva-e@mail.ru  Abstract. In 30% of patients with colorectal cancer, liver metastases are detected. The use of neoadjuvant chemotherapy … Читать далее

POSSIBILITIES OF COMBINED IMMUNOTARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA. LITERATURE REVIEW

K.V. Menshikov1,2, A.V. Sultanbaev1, Sh.I. Musin1, I.R. Rakhmatullina2, I.A. Menshikova2, L.A. Khammatova3, E.V. Popova1, N.I. Sultanbaeva1, D.O. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa 3Children’s City Polyclinic №9, Kazan Menshikov Konstantin V. ― Cand. of Sci. (Med.), Associate Professor of the Department of Oncology with courses on oncology and pathological anatomy … Читать далее

POSSIBILITIES OF THE SECOND LINE OF THERAPY FOR METASTATIC RENAL CELL CARCINOMA. CLINICAL CASE

K.V. Menshikov1,2, A.V. Sultanbaev1, Sh.I. Musin1, I.A. Sharifgaleev1,2, I.A. Menshikova2, N.I. Sultanbaeva1, A.A. Izmailov1,2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Menshikov Konstantin V. ― Cand. of Sci. (Med.), Associate Professor of the Department of Oncology with courses on oncology and pathological anatomy of IAPE of the Bashkir State Medical University; oncologist … Читать далее

SECOND LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA. LITERATURE REVIEW

K.V. Menshikov1,2, A.V. Sultanbaev1, Sh.I. Musin1, A.A. Izmailov1,2, I.A. Menshikova2, L.A. Khammatova3, E.V. Popova1, N.I. Sultanbaeva1, D.O. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa 3Children’s City Polyclinic №9, Kazan Menshikov Konstantin V. ― Cand. of Sci. (Med.), Associate Professor of the Department of Oncology with courses on oncology and pathological anatomy … Читать далее

SELECTION OF MAINTENANCE THERAPY REGIMENS FOR LONG-TERM MANAGEMENT OF PATIENTS WITH COLON CANCER

E.S. Lyubimtseva, O.V. Kokovkina Privolzhsky District Medical Center of the FMBA, Nizhny Novgorod Lyubimtseva Ekaterina S. ― Head of Oncological Department of Anticancer Drug Therapy Privolzhsky District Medical Center of the FMBA 20a Marshal Voronov Str., Nizhny Novgorod, 603074, Russian Federation, tel. (831) 421-83-47, e-mail: Lubimtseva-ek@yandex.ru Abstract. The management of patients with stage IV colorectal … Читать далее